Merck KGaA Acquires Bioscience Company in India

14-Oct-2009 - India

Merck KGaA announced the acquisition of Bangalore Genei (India) Private Ltd. (BGIP) by its wholly owned subsidiary in India, Merck Specialities Private Ltd., from the Sanmar Group.

BGIP is located in Bangalore and specializes in the development, production, marketing and sales of products for proteomic and genomic research. With more than 100 employees, the company generated total revenues of INR 202m (€ 3.0 million) in fiscal year 2008/09.

Christina Shasserre, Global Head of Merck's bioscience business, commented: "BGIP’s leadership in the Indian academic market, a segment with high growth potential, will ideally complement our existing customer base. BGIP’s product portfolio comprises a wide range of bioscience products, which are tailored to the needs of the domestic market in India."

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance